Peroxisome proliferator-activated receptor {alpha} polymorphisms and postprandial lipemia in healthy men
Tanaka et al.
J. Lipid Res. 2007;48:1402-1408.
ABSTRACT
| FULL TEXT
PPAR{alpha} activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes
Edvardsson et al.
J. Lipid Res. 2006;47:329-340.
ABSTRACT
| FULL TEXT
Differential regulation of cytosolic and peroxisomal bile acid amidation by PPAR{alpha} activation favors the formation of unconjugated bile acids
Solaas et al.
J. Lipid Res. 2004;45:1051-1060.
ABSTRACT
| FULL TEXT
Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia
Bilz et al.
J. Lipid Res. 2004;45:174-185.
ABSTRACT
| FULL TEXT
PPAR{alpha} deficiency increases secretion and serum levels of apolipoprotein B-containing lipoproteins
Linden et al.
J. Lipid Res. 2001;42:1831-1840.
ABSTRACT
| FULL TEXT
Fibrates Suppress Bile Acid Synthesis via Peroxisome Proliferator-Activated Receptor-{alpha}-Mediated Downregulation of Cholesterol 7{alpha}-Hydroxylase and Sterol 27-Hydroxylase Expression
Post et al.
Arterioscler. Thromb. Vasc. Bio. 2001;21:1840-1845.
ABSTRACT
| FULL TEXT
The effects of gemfibrozil upon the metabolism of chylomicron-like emulsions in patients with endogenous hypertriglyceridemia
Santos et al.
Cardiovasc Res 2001;49:456-465.
ABSTRACT
| FULL TEXT
Long-term Treatment With Pravastatin Alone and in Combination With Gemfibrozil in Familial Type IIB Hyperlipoproteinemia or Combined Hyperlipidemia
Napoli et al.
J CARDIOVASC PHARMACOL THER 1997;2:17-26.
ABSTRACT
Effects of Different Phenotypes of Hyperlipoproteinemia and of Treatment With Fibric Acid Derivatives on the Rates of Cholesterol 7{alpha}-Hydroxylation in Humans
Bertolotti et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:1064-1069.
ABSTRACT
| FULL TEXT
Lipoprotein Responses to Treatment With Lovastatin, Gemfibrozil, and Nicotinic Acid in Normolipidemic Patients With Hypoalphalipoproteinemia
Vega and Grundy
Arch Intern Med 1994;154:73-82.
ABSTRACT
Pravastatin vs Gemfibrozil in the Treatment of Primary Hypercholesterolemia: The Italian Multicenter Pravastatin Study I
Crepaldi et al.
Arch Intern Med 1991;151:146-152.
ABSTRACT
Cholesterol and Coronary Heart Disease: Future Directions
Grundy
JAMA 1990;264:3053-3059.
ABSTRACT
The Hypolipidemic Effects of Gemfibrozil in Type V Hyperlipidemia: A Double-blind, Crossover Study
Leaf et al.
JAMA 1989;262:3154-3160.
ABSTRACT
Reducing Hypertriglyceridemia in Elderly Patients with Cerebrovascular Disease Stabilizes or Improves Cognition and Cerebral Perfusion
Rogers et al.
ANGIOLOGY 1989;40:260-269.
ABSTRACT
Lipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart Study
Manninen et al.
JAMA 1988;260:641-651.
ABSTRACT
Combination Drug Therapy for Familial Combined Hyperlipidemia
East et al.
ANN INTERN MED 1988;109:25-32.
ABSTRACT
Gemfibrozil Therapy in Primary Hypertriglyceridemia Associated With Coronary Heart Disease: Effects on Metabolism of Low-Density Lipoproteins
Vega and Grundy
JAMA 1985;253:2398-2403.
ABSTRACT
The Peroxisome Proliferator-activated Receptor alpha (PPARalpha ) Regulates Bile Acid Biosynthesis
Hunt et al.
J. Biol. Chem. 2000;275:28947-28953.
ABSTRACT
| FULL TEXT